Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil J Stone

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
Circulation|July 14, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
The American Journal of Medicine|May 20, 2019
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health SystemXiaoming Jia, Mahmoud Al Rifai, David J Ramsey, et al.
Journal of the American College of Cardiology|August 1, 2021
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight CommitteeSalim S Virani, Pamela B Morris, Anandita Agarwala, et al.
Journal of the American College of Cardiology|August 3, 2019
Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol GuidelinesSalim S Virani, Julia M Akeroyd, Sidney C Smith, et al.
Progress in Cardiovascular Diseases|August 29, 2022
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination SurveyKartik Gupta, Tanya S Kakar, Vardhmaan Jain, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 6, 2019
A Clinician's Guide to Healthy Eating for Cardiovascular Disease PreventionVincent A Pallazola, Dorothy M Davis, Seamus P Whelton, et al.
American Heart Journal|January 28, 2019
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected personsRobert A Riestenberg, Andrew Furman, Avery Cowen, et al.
Journal of the American College of Cardiology|February 25, 2022
Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art ReviewNeil J Stone, Sidney C Smith, Carl E Orringer, et al.
European Heart Journal|July 4, 2025
Cumulative exposure to atherogenic lipoprotein particles in young adults and subsequent incident atherosclerotic cardiovascular diseaseAlexander R Zheutlin, Faheem Handoo, Samuel Luebbe, et al.
Mayo Clinic Proceedings|September 17, 2021
High-Intensity Statins Benefit High-Risk Patients: Why and How to Do BetterScott M Grundy, Neil J Stone, Roger S Blumenthal, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Circulation|July 14, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesScott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
The American Journal of Medicine|May 20, 2019
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health SystemXiaoming Jia, Mahmoud Al Rifai, David J Ramsey, et al.
Journal of the American College of Cardiology|August 1, 2021
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight CommitteeSalim S Virani, Pamela B Morris, Anandita Agarwala, et al.
Journal of the American College of Cardiology|August 3, 2019
Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol GuidelinesSalim S Virani, Julia M Akeroyd, Sidney C Smith, et al.
Progress in Cardiovascular Diseases|August 29, 2022
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination SurveyKartik Gupta, Tanya S Kakar, Vardhmaan Jain, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 6, 2019
A Clinician's Guide to Healthy Eating for Cardiovascular Disease PreventionVincent A Pallazola, Dorothy M Davis, Seamus P Whelton, et al.
American Heart Journal|January 28, 2019
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected personsRobert A Riestenberg, Andrew Furman, Avery Cowen, et al.
Journal of the American College of Cardiology|February 25, 2022
Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art ReviewNeil J Stone, Sidney C Smith, Carl E Orringer, et al.
European Heart Journal|July 4, 2025
Cumulative exposure to atherogenic lipoprotein particles in young adults and subsequent incident atherosclerotic cardiovascular diseaseAlexander R Zheutlin, Faheem Handoo, Samuel Luebbe, et al.
Mayo Clinic Proceedings|September 17, 2021
High-Intensity Statins Benefit High-Risk Patients: Why and How to Do BetterScott M Grundy, Neil J Stone, Roger S Blumenthal, et al.
Pageof 21